Published Date: 06 Mar 2023
Maharashtra: The Maharashtra University of Health Sciences (MUHS) has issued the notification of completion of the matrix list of seats by the course for:
Read Full NewsA lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.
An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.
1.
Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma
2.
Researchers find distinct cell receptors with the potential for new treatments.
3.
A study outlines the need for policies that enhance cancer patients' autonomy and information.
4.
Rural residents continue to have higher odds of skin cancer, study finds
5.
Alone for 500 Days, but Never Lonely: The Introvert's Dream.
1.
Synovial Sarcoma of Female Urethra: Case Report and Literature Review
2.
Clonal Hematopoiesis as a Mechanism of Age-Related Disease
3.
Breaking Down Amyloidosis: Understanding the Disease
4.
Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment
5.
Teaching Hematology Through Morphology-Based Learning
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
Navigating the Complexities of Ph Negative ALL - Part IV
3.
Navigating the Complexities of Ph Negative ALL - Part XIV
4.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
5.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation